Rhumbline Advisers Greenwich Life Sciences, Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 9,673 shares of GLSI stock, worth $86,573. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,673
Previous 6,505
48.7%
Holding current value
$86,573
Previous $73,000
36.99%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GLSI
# of Institutions
40Shares Held
1.11MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$2.76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA275KShares$2.46 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA134KShares$1.2 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL87.4KShares$782,4350.0% of portfolio
-
Credit Agricole S A87KShares$778,6490.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $115M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...